Clinical Trial Update: Brentuximab for Newly Diagnosed Hodgkin Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating brentuximab for newly diagnosed Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Brentuximab (brentuximab)

Snippet

Sponsor: Mitchell Cairo | Conditions: Hodgkin Lymphoma | Phase 2 | Status: COMPLETED